The drugs have similar side effects, but Mounjaro side effects may be more numerous and more severe
Ofev (nintedanib) Disease area(s): Respiratory Manufacturer(s): Boehringer Ingelheim 2024 Sales (USD): $4.07 billion Why it sold so well: In 2024, Boehringer Ingelheims Ofev achieved significant commercial success, with global sales reaching 3.77 billion ($4.07 billion), marking a 7.3% increase at constant exchange rates compared to the previous year
Increased plasma estrone and estradiol levels at atrazine doses of 50200 mg/kg/day were associated with elevated aromatase expression and impaired fluid absorption in the efferent ductules of the testes
Additionally, peptides like SS-31 can also influence growth factors, promoting cellular growth and repair
Join us next week for another episode and be sure to follow the show on Apple Podcasts, YouTube, or wherever you get your podcasts so that you never miss another episode